瘙癢藥物的全球市場:2022～2026年

全球瘙癢藥物的市場規模在2022年～2026年間，預測將成長到68億7,000萬美元，在預測期間內年複合成長率預計將為8.06％。

市場成長的主要因素有對免疫療法的偏好提升，慢性疾病的盛行率上升，治療藥的認識提升和使用率上升。

本報告提供全球瘙癢藥物市場相關調查分析，提供市場規模，波特的五力分析，各用途市場市場區隔，客戶形勢，地區形勢，業者情勢，供應商分析等資訊。

目錄

第1章 摘要整理

• 市場概要

第2章 市場形勢

• 市場生態系統

第3章 市場規模

• 市場定義
• 市場區隔分析
• 市場規模:2021年
• 市場預測:預測(2021～2026年)

第4章 波特的五力分析

• 五力的摘要
• 買方議價能力
• 供給企業談判力
• 新加入廠商業者的威脅
• 替代品的威脅
• 對手的威脅
• 市場情況

第5章 市場區隔:各用途

• 市場區隔
• 比較:各用途
• 血液性瘙癢症:市場規模與預測(2021～2026年)
• 腫瘤性瘙癢症:市場規模與預測(2021～2026年)
• 腎性瘙癢症:市場規模與預測(2021～2026年)
• 內分泌性瘙癢症:市場規模與預測(2021～2026年)
• 膽汁淤積性瘙癢症:市場規模與預測(2021～2026年)
• 市場機會:各用途

第6章 客戶形勢

• 客戶形勢概要

第7章 地區形勢

• 地區市場區隔
• 地區比較
• 北美:市場規模與預測(2021～2026年)
• 歐洲:市場規模與預測(2021～2026年)
• 亞洲:市場規模與預測(2021～2026年)
• 其他地區(ROW):市場規模與預測(2021～2026年)
• 美國:市場規模與預測(2021～2026年)
• 英國:市場規模與預測(2021～2026年)
• 德國:市場規模與預測(2021～2026年)
• 中國:市場規模與預測(2021～2026年)
• 法國:市場規模與預測(2021～2026年)
• 市場機會:各地區形勢

第8章 促進因素，課題，及趨勢

• 市場促進因素
• 市場課題
• 推動因素與課題的影響
• 市場趨勢

第9章 業者情勢

• 概要
• 業者情勢
• 創新的形勢
• 產業的風險

第10章 供應商分析

• 交易廠商
• 供應商的市場定位
• AbbVie Inc.
• Astellas Pharma Inc.
• Cara Therapeutics Inc.
• GlaxoSmithKline Plc
• Lupin Ltd.
• Merck and Co. Inc.
• Novartis AG
• Pfizer Inc.
• Roivant Sciences Ltd.
• Sanofi SA

第11章 附錄

• 調查範圍
• 納入和排除清單
• 貨幣換算比率(美元)
• 調查手法
• 簡稱的清單

Technavio has been monitoring the pruritus drugs market and it is poised to grow by $ 6.87 bn during 2022-2026, progressing at a CAGR of 8.06% during the forecast period. Our report on the pruritus drugs market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current global market scenario, latest trends and drivers, and the overall market environment. The market is driven by the growing preference for immunotherapy, rising prevalence of chronic diseases, and increasing awareness and rising use of therapeutics. In addition, the growing preference for immunotherapy is anticipated to boost the growth of the market as well.

The pruritus drugs market analysis includes the application segment and geographic landscape.

Technavio's pruritus drugs market is segmented as below:

By Application

• Hematologic pruritus
• Oncological pruritus
• Renal pruritus
• Endocrine pruritus
• Cholestatic pruritus

By Geographical Landscape

• North America
• Europe
• Asia
• Rest of World (ROW

This study identifies the emergence of novel treatment options as one of the prime reasons driving the pruritus drugs market growth during the next few years. Also, nanoparticle-enabled transdermal drug delivery systems and increasing research funding will lead to sizable demand in the market.

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters. Our report on pruritus drugs market covers the following areas:

• Pruritus drugs market sizing
• Pruritus drugs market forecast
• Pruritus drugs market industry analysis

Technavio's robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading pruritus drugs market vendors that include AbbVie Inc., Almirall SA, Astellas Pharma Inc., Bristol-Myers Squibb Co., Cara Therapeutics Inc., Eisai Co. Ltd., Eli Lilly and Co., Glenmark Pharmaceuticals Ltd., Ipca Laboratories Ltd., Merck and Co. Inc., Novartis AG, Pfizer Inc., Roivant Sciences Ltd., Sanofi SA, Sun Pharmaceutical Industries Ltd., Cipla Ltd., GlaxoSmithKline Plc, and Lupin Ltd. Also, the pruritus drugs market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. Technavio's market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.

Table of Contents

1 Executive Summary

• 1.1 Market overview
• Exhibit 01: Executive Summary - Chart on Market Overview
• Exhibit 02: Executive Summary - Data Table on Market Overview
• Exhibit 03: Executive Summary - Chart on Global Market Characteristics
• Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
• Exhibit 05: Executive Summary - Chart on Market Segmentation by Application
• Exhibit 06: Executive Summary - Chart on Incremental Growth
• Exhibit 07: Executive Summary - Data Table on Incremental Growth
• Exhibit 08: Executive Summary - Chart on Vendor Market Positioning

2 Market Landscape

• 2.1 Market ecosystem
• Exhibit 09: Parent market
• Exhibit 10: Market Characteristics

3 Market Sizing

• 3.1 Market definition
• Exhibit 11: Offerings of vendors included in the market definition
• 3.2 Market segment analysis
• Exhibit 12: Market segments
• 3.3 Market size 2021
• 3.4 Market outlook: Forecast for 2021-2026
• Exhibit 13: Chart on Global - Market size and forecast 2021-2026 ($ billion)
• Exhibit 14: Data Table on Global - Market size and forecast 2021-2026 ($ billion)
• Exhibit 15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
• Exhibit 16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)

4 Five Forces Analysis

• 4.1 Five forces summary
• Exhibit 17: Five forces analysis - Comparison between 2021 and 2026
• 4.2 Bargaining power of buyers
• Exhibit 18: Bargaining power of buyers - Impact of key factors in 2021 and 2026
• 4.3 Bargaining power of suppliers
• Exhibit 19: Bargaining power of suppliers - Impact of key factors in 2021 and 2026
• 4.4 Threat of new entrants
• Exhibit 20: Threat of new entrants - Impact of key factors in 2021 and 2026
• 4.5 Threat of substitutes
• Exhibit 21: Threat of substitutes - Impact of key factors in 2021 and 2026
• 4.6 Threat of rivalry
• Exhibit 22: Threat of rivalry - Impact of key factors in 2021 and 2026
• 4.7 Market condition
• Exhibit 23: Chart on Market condition - Five forces 2021 and 2026

5 Market Segmentation by Application

• 5.1 Market segments
• Exhibit 24: Chart on Application - Market share 2021-2026 (%)
• Exhibit 25: Data Table on Application - Market share 2021-2026 (%)
• 5.2 Comparison by Application
• Exhibit 26: Chart on Comparison by Application
• Exhibit 27: Data Table on Comparison by Application
• 5.3 Hematologic pruritus - Market size and forecast 2021-2026
• Exhibit 28: Chart on Hematologic pruritus - Market size and forecast 2021-2026 ($ billion)
• Exhibit 29: Data Table on Hematologic pruritus - Market size and forecast 2021-2026 ($ billion)
• Exhibit 30: Chart on Hematologic pruritus - Year-over-year growth 2021-2026 (%)
• Exhibit 31: Data Table on Hematologic pruritus - Year-over-year growth 2021-2026 (%)
• 5.4 Oncological pruritus - Market size and forecast 2021-2026
• Exhibit 32: Chart on Oncological pruritus - Market size and forecast 2021-2026 ($ billion)
• Exhibit 33: Data Table on Oncological pruritus - Market size and forecast 2021-2026 ($ billion)
• Exhibit 34: Chart on Oncological pruritus - Year-over-year growth 2021-2026 (%)
• Exhibit 35: Data Table on Oncological pruritus - Year-over-year growth 2021-2026 (%)
• 5.5 Renal pruritus - Market size and forecast 2021-2026
• Exhibit 36: Chart on Renal pruritus - Market size and forecast 2021-2026 ($ billion)
• Exhibit 37: Data Table on Renal pruritus - Market size and forecast 2021-2026 ($ billion)
• Exhibit 38: Chart on Renal pruritus - Year-over-year growth 2021-2026 (%)
• Exhibit 39: Data Table on Renal pruritus - Year-over-year growth 2021-2026 (%)
• 5.6 Endocrine pruritus - Market size and forecast 2021-2026
• Exhibit 40: Chart on Endocrine pruritus - Market size and forecast 2021-2026 ($ billion)
• Exhibit 41: Data Table on Endocrine pruritus - Market size and forecast 2021-2026 ($ billion)
• Exhibit 42: Chart on Endocrine pruritus - Year-over-year growth 2021-2026 (%)
• Exhibit 43: Data Table on Endocrine pruritus - Year-over-year growth 2021-2026 (%)
• 5.7 Cholestatic pruritus - Market size and forecast 2021-2026
• Exhibit 44: Chart on Cholestatic pruritus - Market size and forecast 2021-2026 ($ billion)
• Exhibit 45: Data Table on Cholestatic pruritus - Market size and forecast 2021-2026 ($ billion)
• Exhibit 46: Chart on Cholestatic pruritus - Year-over-year growth 2021-2026 (%)
• Exhibit 47: Data Table on Cholestatic pruritus - Year-over-year growth 2021-2026 (%)
• 5.8 Market opportunity by Application
• Exhibit 48: Market opportunity by Application ($ billion)

6 Customer Landscape

• 6.1 Customer landscape overview
• Exhibit 49: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

7 Geographic Landscape

• 7.1 Geographic segmentation
• Exhibit 50: Chart on Market share By Geographical Landscape 2021-2026 (%)
• Exhibit 51: Data Table on Market share By Geographical Landscape 2021-2026 (%)
• 7.2 Geographic comparison
• Exhibit 52: Chart on Geographic comparison
• Exhibit 53: Data Table on Geographic comparison
• 7.3 North America - Market size and forecast 2021-2026
• Exhibit 54: Chart on North America - Market size and forecast 2021-2026 ($ billion)
• Exhibit 55: Data Table on North America - Market size and forecast 2021-2026 ($ billion)
• Exhibit 56: Chart on North America - Year-over-year growth 2021-2026 (%)
• Exhibit 57: Data Table on North America - Year-over-year growth 2021-2026 (%)
• 7.4 Europe - Market size and forecast 2021-2026
• Exhibit 58: Chart on Europe - Market size and forecast 2021-2026 ($ billion)
• Exhibit 59: Data Table on Europe - Market size and forecast 2021-2026 ($ billion)
• Exhibit 60: Chart on Europe - Year-over-year growth 2021-2026 (%)
• Exhibit 61: Data Table on Europe - Year-over-year growth 2021-2026 (%)
• 7.5 Asia - Market size and forecast 2021-2026
• Exhibit 62: Chart on Asia - Market size and forecast 2021-2026 ($ billion)
• Exhibit 63: Data Table on Asia - Market size and forecast 2021-2026 ($ billion)
• Exhibit 64: Chart on Asia - Year-over-year growth 2021-2026 (%)
• Exhibit 65: Data Table on Asia - Year-over-year growth 2021-2026 (%)
• 7.6 Rest of World (ROW) - Market size and forecast 2021-2026
• Exhibit 66: Chart on Rest of World (ROW) - Market size and forecast 2021-2026 ($ billion)
• Exhibit 67: Data Table on Rest of World (ROW) - Market size and forecast 2021-2026 ($ billion)
• Exhibit 68: Chart on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
• Exhibit 69: Data Table on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
• 7.7 US - Market size and forecast 2021-2026
• Exhibit 70: Chart on US - Market size and forecast 2021-2026 ($ billion)
• Exhibit 71: Data Table on US - Market size and forecast 2021-2026 ($ billion)
• Exhibit 72: Chart on US - Year-over-year growth 2021-2026 (%)
• Exhibit 73: Data Table on US - Year-over-year growth 2021-2026 (%)
• 7.8 UK - Market size and forecast 2021-2026
• Exhibit 74: Chart on UK - Market size and forecast 2021-2026 ($ billion)
• Exhibit 75: Data Table on UK - Market size and forecast 2021-2026 ($ billion)
• Exhibit 76: Chart on UK - Year-over-year growth 2021-2026 (%)
• Exhibit 77: Data Table on UK - Year-over-year growth 2021-2026 (%)
• 7.9 Germany - Market size and forecast 2021-2026
• Exhibit 78: Chart on Germany - Market size and forecast 2021-2026 ($ billion)
• Exhibit 79: Data Table on Germany - Market size and forecast 2021-2026 ($ billion)
• Exhibit 80: Chart on Germany - Year-over-year growth 2021-2026 (%)
• Exhibit 81: Data Table on Germany - Year-over-year growth 2021-2026 (%)
• 7.10 China - Market size and forecast 2021-2026
• Exhibit 82: Chart on China - Market size and forecast 2021-2026 ($ billion)
• Exhibit 83: Data Table on China - Market size and forecast 2021-2026 ($ billion)
• Exhibit 84: Chart on China - Year-over-year growth 2021-2026 (%)
• Exhibit 85: Data Table on China - Year-over-year growth 2021-2026 (%)
• 7.11 France - Market size and forecast 2021-2026
• Exhibit 86: Chart on France - Market size and forecast 2021-2026 ($ billion)
• Exhibit 87: Data Table on France - Market size and forecast 2021-2026 ($ billion)
• Exhibit 88: Chart on France - Year-over-year growth 2021-2026 (%)
• Exhibit 89: Data Table on France - Year-over-year growth 2021-2026 (%)
• 7.12 Market opportunity By Geographical Landscape
• Exhibit 90: Market opportunity By Geographical Landscape ($ billion)

8 Drivers, Challenges, and Trends

• 8.1 Market drivers
• 8.2 Market challenges
• 8.3 Impact of drivers and challenges
• Exhibit 91: Impact of drivers and challenges in 2021 and 2026
• 8.4 Market trends

9 Vendor Landscape

• 9.1 Overview
• 9.2 Vendor landscape
• Exhibit 92: Overview on Criticality of inputs and Factors of differentiation
• 9.3 Landscape disruption
• Exhibit 93: Overview on factors of disruption
• 9.4 Industry risks
• Exhibit 94: Impact of key risks on business

10 Vendor Analysis

• 10.1 Vendors covered
• Exhibit 95: Vendors covered
• 10.2 Market positioning of vendors
• Exhibit 96: Matrix on vendor position and classification
• 10.3 AbbVie Inc.
• Exhibit 97: AbbVie Inc. - Overview
• Exhibit 98: AbbVie Inc. - Business segments
• Exhibit 99: AbbVie Inc. - Key offerings
• Exhibit 100: AbbVie Inc. - Segment focus
• 10.4 Astellas Pharma Inc.
• Exhibit 101: Astellas Pharma Inc. - Overview
• Exhibit 102: Astellas Pharma Inc. - Product / Service
• Exhibit 103: Astellas Pharma Inc. - Key news
• Exhibit 104: Astellas Pharma Inc. - Key offerings
• 10.5 Cara Therapeutics Inc.
• Exhibit 105: Cara Therapeutics Inc. - Overview
• Exhibit 106: Cara Therapeutics Inc. - Product / Service
• Exhibit 107: Cara Therapeutics Inc. - Key offerings
• 10.6 GlaxoSmithKline Plc
• Exhibit 108: GlaxoSmithKline Plc - Overview
• Exhibit 109: GlaxoSmithKline Plc - Business segments
• Exhibit 110: GlaxoSmithKline Plc - Key news
• Exhibit 111: GlaxoSmithKline Plc - Key offerings
• Exhibit 112: GlaxoSmithKline Plc - Segment focus
• 10.7 Lupin Ltd.
• Exhibit 113: Lupin Ltd. - Overview
• Exhibit 114: Lupin Ltd. - Product / Service
• Exhibit 115: Lupin Ltd. - Key news
• Exhibit 116: Lupin Ltd. - Key offerings
• 10.8 Merck and Co. Inc.
• Exhibit 117: Merck and Co. Inc. - Overview
• Exhibit 118: Merck and Co. Inc. - Business segments
• Exhibit 119: Merck and Co. Inc. - Key news
• Exhibit 120: Merck and Co. Inc. - Key offerings
• Exhibit 121: Merck and Co. Inc. - Segment focus
• 10.9 Novartis AG
• Exhibit 122: Novartis AG - Overview
• Exhibit 123: Novartis AG - Business segments
• Exhibit 124: Novartis AG - Key offerings
• Exhibit 125: Novartis AG - Segment focus
• 10.10 Pfizer Inc.
• Exhibit 126: Pfizer Inc. - Overview
• Exhibit 127: Pfizer Inc. - Business segments
• Exhibit 128: Pfizer Inc. - Key news
• Exhibit 129: Pfizer Inc. - Key offerings
• Exhibit 130: Pfizer Inc. - Segment focus
• 10.11 Roivant Sciences Ltd.
• Exhibit 131: Roivant Sciences Ltd. - Overview
• Exhibit 132: Roivant Sciences Ltd. - Product / Service
• Exhibit 133: Roivant Sciences Ltd. - Key offerings
• 10.12 Sanofi SA
• Exhibit 134: Sanofi SA - Overview
• Exhibit 135: Sanofi SA - Business segments
• Exhibit 136: Sanofi SA - Key news
• Exhibit 137: Sanofi SA - Key offerings
• Exhibit 138: Sanofi SA - Segment focus

11 Appendix

• 11.1 Scope of the report
• 11.2 Inclusions and exclusions checklist
• Exhibit 139: Inclusions checklist
• Exhibit 140: Exclusions checklist
• 11.3 Currency conversion rates for US$
• Exhibit 141: Currency conversion rates for US$
• 11.4 Research methodology
• Exhibit 142: Research methodology
• Exhibit 143: Validation techniques employed for market sizing
• Exhibit 144: Information sources
• 11.5 List of abbreviations
• Exhibit 145: List of abbreviations

Exhibits

• Exhibits1: Executive Summary - Chart on Market Overview
• Exhibits2: Executive Summary - Data Table on Market Overview
• Exhibits3: Executive Summary - Chart on Global Market Characteristics
• Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
• Exhibits5: Executive Summary - Chart on Market Segmentation by Application
• Exhibits6: Executive Summary - Chart on Incremental Growth
• Exhibits7: Executive Summary - Data Table on Incremental Growth
• Exhibits8: Executive Summary - Chart on Vendor Market Positioning
• Exhibits9: Parent market
• Exhibits10: Market Characteristics
• Exhibits11: Offerings of vendors included in the market definition
• Exhibits12: Market segments
• Exhibits13: Chart on Global - Market size and forecast 2021-2026 ($ billion)
• Exhibits14: Data Table on Global - Market size and forecast 2021-2026 ($ billion)
• Exhibits15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
• Exhibits16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)
• Exhibits17: Five forces analysis - Comparison between 2021 and 2026
• Exhibits18: Bargaining power of buyers - Impact of key factors in 2021 and 2026
• Exhibits19: Bargaining power of suppliers - Impact of key factors in 2021 and 2026
• Exhibits20: Threat of new entrants - Impact of key factors in 2021 and 2026
• Exhibits21: Threat of substitutes - Impact of key factors in 2021 and 2026
• Exhibits22: Threat of rivalry - Impact of key factors in 2021 and 2026
• Exhibits23: Chart on Market condition - Five forces 2021 and 2026
• Exhibits24: Chart on Application - Market share 2021-2026 (%)
• Exhibits25: Data Table on Application - Market share 2021-2026 (%)
• Exhibits26: Chart on Comparison by Application
• Exhibits27: Data Table on Comparison by Application
• Exhibits28: Chart on Hematologic pruritus - Market size and forecast 2021-2026 ($ billion)
• Exhibits29: Data Table on Hematologic pruritus - Market size and forecast 2021-2026 ($ billion)
• Exhibits30: Chart on Hematologic pruritus - Year-over-year growth 2021-2026 (%)
• Exhibits31: Data Table on Hematologic pruritus - Year-over-year growth 2021-2026 (%)
• Exhibits32: Chart on Oncological pruritus - Market size and forecast 2021-2026 ($ billion)
• Exhibits33: Data Table on Oncological pruritus - Market size and forecast 2021-2026 ($ billion)
• Exhibits34: Chart on Oncological pruritus - Year-over-year growth 2021-2026 (%)
• Exhibits35: Data Table on Oncological pruritus - Year-over-year growth 2021-2026 (%)
• Exhibits36: Chart on Renal pruritus - Market size and forecast 2021-2026 ($ billion)
• Exhibits37: Data Table on Renal pruritus - Market size and forecast 2021-2026 ($ billion)
• Exhibits38: Chart on Renal pruritus - Year-over-year growth 2021-2026 (%)
• Exhibits39: Data Table on Renal pruritus - Year-over-year growth 2021-2026 (%)
• Exhibits40: Chart on Endocrine pruritus - Market size and forecast 2021-2026 ($ billion)
• Exhibits41: Data Table on Endocrine pruritus - Market size and forecast 2021-2026 ($ billion)
• Exhibits42: Chart on Endocrine pruritus - Year-over-year growth 2021-2026 (%)
• Exhibits43: Data Table on Endocrine pruritus - Year-over-year growth 2021-2026 (%)
• Exhibits44: Chart on Cholestatic pruritus - Market size and forecast 2021-2026 ($ billion)
• Exhibits45: Data Table on Cholestatic pruritus - Market size and forecast 2021-2026 ($ billion)
• Exhibits46: Chart on Cholestatic pruritus - Year-over-year growth 2021-2026 (%)
• Exhibits47: Data Table on Cholestatic pruritus - Year-over-year growth 2021-2026 (%)
• Exhibits48: Market opportunity by Application ($ billion)
• Exhibits49: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• Exhibits50: Chart on Market share By Geographical Landscape 2021-2026 (%)
• Exhibits51: Data Table on Market share By Geographical Landscape 2021-2026 (%)
• Exhibits52: Chart on Geographic comparison
• Exhibits53: Data Table on Geographic comparison
• Exhibits54: Chart on North America - Market size and forecast 2021-2026 ($ billion)
• Exhibits55: Data Table on North America - Market size and forecast 2021-2026 ($ billion)
• Exhibits56: Chart on North America - Year-over-year growth 2021-2026 (%)
• Exhibits57: Data Table on North America - Year-over-year growth 2021-2026 (%)
• Exhibits58: Chart on Europe - Market size and forecast 2021-2026 ($ billion)
• Exhibits59: Data Table on Europe - Market size and forecast 2021-2026 ($ billion)
• Exhibits60: Chart on Europe - Year-over-year growth 2021-2026 (%)
• Exhibits61: Data Table on Europe - Year-over-year growth 2021-2026 (%)
• Exhibits62: Chart on Asia - Market size and forecast 2021-2026 ($ billion)
• Exhibits63: Data Table on Asia - Market size and forecast 2021-2026 ($ billion)
• Exhibits64: Chart on Asia - Year-over-year growth 2021-2026 (%)
• Exhibits65: Data Table on Asia - Year-over-year growth 2021-2026 (%)
• Exhibits66: Chart on Rest of World (ROW) - Market size and forecast 2021-2026 ($ billion)
• Exhibits67: Data Table on Rest of World (ROW) - Market size and forecast 2021-2026 ($ billion)
• Exhibits68: Chart on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
• Exhibits69: Data Table on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
• Exhibits70: Chart on US - Market size and forecast 2021-2026 ($ billion)
• Exhibits71: Data Table on US - Market size and forecast 2021-2026 ($ billion)
• Exhibits72: Chart on US - Year-over-year growth 2021-2026 (%)
• Exhibits73: Data Table on US - Year-over-year growth 2021-2026 (%)
• Exhibits74: Chart on UK - Market size and forecast 2021-2026 ($ billion)
• Exhibits75: Data Table on UK - Market size and forecast 2021-2026 ($ billion)
• Exhibits76: Chart on UK - Year-over-year growth 2021-2026 (%)
• Exhibits77: Data Table on UK - Year-over-year growth 2021-2026 (%)
• Exhibits78: Chart on Germany - Market size and forecast 2021-2026 ($ billion)
• Exhibits79: Data Table on Germany - Market size and forecast 2021-2026 ($ billion)
• Exhibits80: Chart on Germany - Year-over-year growth 2021-2026 (%)
• Exhibits81: Data Table on Germany - Year-over-year growth 2021-2026 (%)
• Exhibits82: Chart on China - Market size and forecast 2021-2026 ($ billion)
• Exhibits83: Data Table on China - Market size and forecast 2021-2026 ($ billion)
• Exhibits84: Chart on China - Year-over-year growth 2021-2026 (%)
• Exhibits85: Data Table on China - Year-over-year growth 2021-2026 (%)
• Exhibits86: Chart on France - Market size and forecast 2021-2026 ($ billion)
• Exhibits87: Data Table on France - Market size and forecast 2021-2026 ($ billion)
• Exhibits88: Chart on France - Year-over-year growth 2021-2026 (%)
• Exhibits89: Data Table on France - Year-over-year growth 2021-2026 (%)
• Exhibits90: Market opportunity By Geographical Landscape ($ billion)
• Exhibits91: Impact of drivers and challenges in 2021 and 2026
• Exhibits92: Overview on Criticality of inputs and Factors of differentiation
• Exhibits93: Overview on factors of disruption
• Exhibits94: Impact of key risks on business
• Exhibits95: Vendors covered
• Exhibits96: Matrix on vendor position and classification
• Exhibits97: AbbVie Inc. - Overview
• Exhibits98: AbbVie Inc. - Business segments
• Exhibits99: AbbVie Inc. - Key offerings
• Exhibits100: AbbVie Inc. - Segment focus
• Exhibits101: Astellas Pharma Inc. - Overview
• Exhibits102: Astellas Pharma Inc. - Product / Service
• Exhibits103: Astellas Pharma Inc. - Key news
• Exhibits104: Astellas Pharma Inc. - Key offerings
• Exhibits105: Cara Therapeutics Inc. - Overview
• Exhibits106: Cara Therapeutics Inc. - Product / Service
• Exhibits107: Cara Therapeutics Inc. - Key offerings
• Exhibits108: GlaxoSmithKline Plc - Overview
• Exhibits109: GlaxoSmithKline Plc - Business segments
• Exhibits110: GlaxoSmithKline Plc - Key news
• Exhibits111: GlaxoSmithKline Plc - Key offerings
• Exhibits112: GlaxoSmithKline Plc - Segment focus
• Exhibits113: Lupin Ltd. - Overview
• Exhibits114: Lupin Ltd. - Product / Service
• Exhibits115: Lupin Ltd. - Key news
• Exhibits116: Lupin Ltd. - Key offerings
• Exhibits117: Merck and Co. Inc. - Overview
• Exhibits118: Merck and Co. Inc. - Business segments
• Exhibits119: Merck and Co. Inc. - Key news
• Exhibits120: Merck and Co. Inc. - Key offerings
• Exhibits121: Merck and Co. Inc. - Segment focus
• Exhibits122: Novartis AG - Overview
• Exhibits123: Novartis AG - Business segments
• Exhibits124: Novartis AG - Key offerings
• Exhibits125: Novartis AG - Segment focus
• Exhibits126: Pfizer Inc. - Overview
• Exhibits127: Pfizer Inc. - Business segments
• Exhibits128: Pfizer Inc. - Key news
• Exhibits129: Pfizer Inc. - Key offerings
• Exhibits130: Pfizer Inc. - Segment focus
• Exhibits131: Roivant Sciences Ltd. - Overview
• Exhibits132: Roivant Sciences Ltd. - Product / Service
• Exhibits133: Roivant Sciences Ltd. - Key offerings
• Exhibits134: Sanofi SA - Overview
• Exhibits135: Sanofi SA - Business segments
• Exhibits136: Sanofi SA - Key news
• Exhibits137: Sanofi SA - Key offerings
• Exhibits138: Sanofi SA - Segment focus
• Exhibits139: Inclusions checklist
• Exhibits140: Exclusions checklist
• Exhibits141: Currency conversion rates for US$
• Exhibits142: Research methodology
• Exhibits143: Validation techniques employed for market sizing
• Exhibits144: Information sources
• Exhibits145: List of abbreviations